| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273927 Mdm2 splice variants |
| 09/25/2007 | US7273926 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 09/25/2007 | US7273925 Methods and products for regulating lectin complement pathway associated complement activation |
| 09/25/2007 | US7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses |
| 09/25/2007 | US7273921 Method for producing acylated peptides |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273740 Enzymes having alpha amylase activity and methods of use thereof |
| 09/25/2007 | US7273727 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 09/25/2007 | US7273726 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 09/25/2007 | US7273725 Human and mammalian stem cell-derived neuron survival factors |
| 09/25/2007 | US7273615 Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same |
| 09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/25/2007 | US7273610 Endotheliase-2 ligands |
| 09/25/2007 | US7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 09/25/2007 | US7273608 Humanized anti-CEA T84.66 antibody and uses thereof |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2214018C An immortalized mammal hybridoma fusion partner |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/25/2007 | CA2132868C Method of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 09/25/2007 | CA2112701C Proteins s polypeptides and uses thereof |
| 09/20/2007 | WO2007106744A2 Anti-5t4 antibodies and uses thereof |
| 09/20/2007 | WO2007106448A1 Methods for making antibodies in genetically engineered mice |
| 09/20/2007 | WO2007105894A1 Growth inhibitory composition against pathogenic bacteria of meat based food stuff comprising igy |
| 09/20/2007 | WO2007104529A2 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 09/20/2007 | WO2007104511A1 Cancer vaccine |
| 09/20/2007 | WO2007104143A1 METHODS FOR DIAGNOSIS AND PROGNOSIS OF GRAFT VERSUS HOST DISEASE BY MEASUREMENT OF PERIPHERAL CD3+CD4+CD8β+ CELLS |
| 09/20/2007 | WO2007082715A3 Anti-cd19 antibody composition and method |
| 09/20/2007 | WO2007071250A3 Method for detection of l523s expression in biological samples |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007058823A3 Anti-egfr antibodies |
| 09/20/2007 | WO2007048122A3 Antibody-based therapeutics with enhanced adcc activity |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2006119107A9 Sclerostin binding agents |
| 09/20/2007 | WO2006048174A8 Immunoglobulin fractions |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | WO2005011590A3 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 09/20/2007 | WO2004009834A3 Novel nucleic acids and secreted polypeptides |
| 09/20/2007 | US20070220620 TAT-046 and methods of assessing and treating cancer |
| 09/20/2007 | US20070219354 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 09/20/2007 | US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens |
| 09/20/2007 | US20070219264 inhibiting rejection of a transplanted organ, tissue or cell in a recipient mammal; immunosuppressive agent; autoimmune diseases |
| 09/20/2007 | US20070219147 Insect Chymotrypsin and Inhibitors Thereof |
| 09/20/2007 | US20070219133 CD52 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION |
| 09/20/2007 | US20070219125 Novel thrombospondin-1 polynucleotides encoding variant thrombospondin-1 polypeptides and methods using same |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218516 Recombinant chimeric human anti-botulinum antibodies |
| 09/20/2007 | US20070218507 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 09/20/2007 | US20070218506 Immunoassays for Buprenorphine and Norbuprenorphine |
| 09/20/2007 | US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 09/20/2007 | US20070218499 Monoclonal Antibodies That Target Pathological Assemblies Of Amyloid B (Abeta) |
| 09/20/2007 | US20070218463 Rearranged squamous cell carcinoma antigen genes II |
| 09/20/2007 | US20070218082 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 09/20/2007 | US20070218080 Peptide antigen of human papillomavirus type 16 and application thereof |
| 09/20/2007 | US20070218071 Novel therapeutic targets in cancer |
| 09/20/2007 | US20070218069 antibodies that specifically binds ubiquitin comprising a lysine linkage between a lysine residue of one ubiquitin molecule and the C-terminal glycine residue of another ubiquitin molecule |
| 09/20/2007 | US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors |
| 09/20/2007 | US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal |
| 09/20/2007 | US20070218065 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 09/20/2007 | US20070218064 Human anti-il-23 antibodies, compositions, methods and uses |
| 09/20/2007 | US20070218060 Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple Myeloma |
| 09/20/2007 | US20070218059 Cell Surface Marker |
| 09/20/2007 | US20070218058 Methods For Inducing Autolysis In Infectious Bacteria |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218052 Novel lgG3 Antibodies for Stimulating Phagocytosis |
| 09/20/2007 | US20070218048 Sfec, a Sperm Flagellar Energy Carrier Protein |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | US20070218001 Biotherapeutics, Diagnostics and Research Reagents |
| 09/20/2007 | US20070217997 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 09/20/2007 | CA2646513A1 Antibodies to egfl7 and methods for their use |
| 09/20/2007 | CA2646495A1 In vivo induced genes of mycobacterium tuberculosis |
| 09/20/2007 | CA2646478A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 09/20/2007 | CA2645097A1 Anti-5t4 antibodies and uses thereof |
| 09/20/2007 | CA2644903A1 Identification and engineering of antibodies with variant heavy chains and methods of using same |
| 09/20/2007 | CA2644405A1 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 09/20/2007 | CA2643737A1 Cancer vaccine |
| 09/19/2007 | EP1835285A1 ERCC1 expression in predicting response for cancer chemotherapy |
| 09/19/2007 | EP1835027A1 Novel cancer antigen peptide and the use thereof |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834671A2 A method for generation of antibodies to cell surface molecules |
| 09/19/2007 | EP1833970A2 Methods for producing soluble multi-membrane-spanning proteins |
| 09/19/2007 | EP1833964A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 09/19/2007 | EP1833850A1 Framework residue substituted humanized col-1 antibodies and their use |
| 09/19/2007 | EP1833849A2 Fc gamma riib-specific antibodies and methods of use thereof |
| 09/19/2007 | EP1833510A2 Orally deliverable and anti-toxin antibodies and methods for making and using them |
| 09/19/2007 | EP1317553B1 Pde8a and uses thereof |
| 09/19/2007 | EP1257644B1 103p2d6: tissue specific protein highly expressed in various cancers |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | EP1232260B1 Polymorphism in the human mdr-1 gene and applications thereof |
| 09/19/2007 | EP1190071B1 17867, a novel human aminopeptidase |
| 09/19/2007 | EP1151304B1 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 09/19/2007 | EP1142995B1 Antiuracil monoclonal antibody |
| 09/19/2007 | EP1020522B1 Natural human antibody |
| 09/19/2007 | EP0979278B1 Methods for detecting resistance to macrocyclic lactone compounds |
| 09/19/2007 | EP0960114B1 Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101039960A Chimeric and humanised monoclonal antibodies against interleukin-13 |
| 09/19/2007 | CN101039959A Compositions and methods for treating inflammatory disorders |